Clinical and Immunologic Features of Germline Pathogenic Variant (gPV) Positive Patients with Melanoma.
Alan ShenMichelle ArbesmanRoshan LodhaPatricia A RaymanBrandon BungoYing NiTimothy A ChanBrian R GastmanJennifer Susan KoC Marcela Diaz-MonteroJoshua ArbesmanPauline FunchainPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
gPV positive patients with melanoma exhibit improved MSS in addition to reduced peripheral PMN-MDSCs and an enhanced inflammatory microenvironment.